{
    "applicationNumber": "BR 11 2021 009275-7",
    "filingDate": "15/11/2019",
    "grantDate": null,
    "title": "ANTICORPO HUMANIZADO ANTI-SIRP ALFA OU UM FRAGMENTO DE LIGA\u00c7\u00c3O A ANT\u00cdGENO DO MESMO, COMPOSI\u00c7\u00c3O FARMAC\u00caUTICA, MOL\u00c9CULA DE \u00c1CIDO NUCLEICO, E, C\u00c9LULA HOSPEDEIRA.",
    "nationalPhaseDate": [
        "13/05/2021"
    ],
    "internationalApplication": {
        "pctNumber": "PCT EP2019/081523",
        "pctDate": "15/11/2019",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "EP",
            "priorityNumber": "18206594.6",
            "priorityDate": "15/11/2018"
        }
    ],
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2629"
        },
        {
            "code": "1.5",
            "description": "Exig\u00eancias Diversas",
            "bulletinNumber ": "2641"
        },
        {
            "code": "1.5",
            "description": "Exig\u00eancias Diversas",
            "bulletinNumber ": "2651"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2661"
        }
    ],
    "inventors": [
        "GIJSBERTUS FRANCISCUS MARIA VERHEIJDEN"
    ],
    "holders": [
        177151
    ],
    "ipcCodes": [
        "A61P 35/00",
        "A61K 39/00",
        "C07K 16/28"
    ]
}